Entirely subcutaneous defibrillator and complex congenital heart disease: Data on long-term clinical follow-up

Figure 1 A new transeptal endocardial lead was implanted in the left ventricle and the atrial septal defect was thereafter successfully closed with an occlude device. A: Subcutaneous implantable cardiac defibrillator and endocardial pacing system in a patient post Mustard operation; B: Patient with ASD and dilatative DCM who previously underwent left ventricle lead implant; C: Patient with Eisenmenger syndrome. ASD: Atrial septal defect; DCM: Dilatative cardiomyopathy.